Co-Authors
This is a "connection" page, showing publications co-authored by Giovanni Guaraldi and Gianni Cappelli.
Connection Strength
1.146
-
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants. Clin Kidney J. 2021 Aug; 14(8):1983-1984.
Score: 0.234
-
Kidney Disease in HIV Infection. J Clin Med. 2019 Aug 19; 8(8).
Score: 0.210
-
Immunophenotypic profile and clinical outcome of monoclonal B-cell lymphocytosis in kidney transplantation. Clin Transplant. 2018 08; 32(8):e13338.
Score: 0.196
-
One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19. Hemodial Int. 2021 10; 25(4):E53-E56.
Score: 0.060
-
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
Score: 0.060
-
Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb; 54(2):405-410.
Score: 0.059
-
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients. Kidney Res Clin Pract. 2021 Jun; 40(2):231-240.
Score: 0.059
-
Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021 Apr; 25(4):401-409.
Score: 0.058
-
Long-term effects of COVID-19 in a patient on maintenance dialysis. Hemodial Int. 2020 10; 24(4):E50-E54.
Score: 0.056
-
Peritoneal dialysis in the time of coronavirus disease 2019. Clin Kidney J. 2020 Jun; 13(3):265-268.
Score: 0.056
-
The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection. Blood Purif. 2021; 50(2):263-267.
Score: 0.055
-
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study. Transplant Direct. 2017 Jul; 3(7):e182.
Score: 0.045